Extracellular drug conjugates (EDCs) targeting CD38 are useful in the treatment of diseases such as cancer and immune disorders, including asthma.Conjugués de médicaments (EDC) ciblant CD38 utiles dans le traitement de maladies, telles que le cancer et les troubles immunitaires, y compris l'asthme.